4.5 Article

Effects of work status changes and perceived stress on glycaemic control in individuals with type 1 diabetes during COVID-19 lockdown in Italy

期刊

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2020.108513

关键词

COVID-19; Lockdown; Stress; Glycaemic control; Type 1 diabetes

资金

  1. Sapienza University of Rome [201800, RM1181643647A86E]
  2. Eli Lilly Foundation

向作者/读者索取更多资源

Aims: To evaluate the effects of COVID-19 lockdown on blood glucose control in individuals with type 1 diabetes (T1D) and to explore determinants of glucose variability. Methods: Fifty T1D patients undergoing continuous/flash glucose monitoring were recruited. The study's primary outcome was the change of time in range (TIR) from before to lockdown period. Three time-point comparisons of TIR, mean glucose levels (MG), estimated (e)HbA1c, time above (TAR) and below range (TBR), moderate/severe hypoglycemic events between pre-lockdown, lockdown and post-lockdown period were also performed. Information on lockdown-associated perceived stress, changes of work status and physical activity were recorded. Results: TIR significantly decreased (75(63-84)% vs. 69(50-76)%, p < 0.001) whereas MG (15 4 +/- 15 mg/dl vs. 165 +/- 25 mg/dl, p = 0.027) and eHbA1c (7.3(6.6-7.8)% vs. 7.5(6.7-8.2)%, p = 0.031) increased from preto lockdown period; overall glucose control significantly improved when restriction ended. Lockdown-associated work loss/suspension independently predicted impaired TIR after adjustment for potential confounders (Standardized b: -0.29; 95%C Iota: -18.7 to -2.25; p = 0.01). Greater TAR, TBR and hypoglycemic events were also reported during the lockdown. Conclusion: In T1D Italian individuals, blood glucose control significantly worsened during the COVID- 19 lockdown; work instability and related issues represented the main determinant of impaired glucose variability in this population. (c) 2020 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease

Ilaria Barchetta, Carla Lubrano, Flavia Agata Cimini, Sara Dule, Giulia Passarella, Arianna Dellanno, Alberto Di Biasio, Frida Leonetti, Gianfranco Silecchia, Andrea Lenzi, Maria Gisella Cavallo

Summary: This study found a close relationship between NAFLD-related liver fibrosis, lower bone mineral density, and degraded microarchitecture in obese individuals. This suggests potential common pathways underlying liver and bone involvement in obesity and insulin resistance-associated disorders.

HEPATOLOGY INTERNATIONAL (2023)

Article Cardiac & Cardiovascular Systems

A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes

D. Bruttomesso, C. Irace, P. Pozzilli

Summary: This study reported on glycemic control in Italian participants with type 1 diabetes and found that younger patients had better glycemic control compared to older patients. Factors such as body mass index and adherence to diet were associated with glycemic control.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2023)

Article Endocrinology & Metabolism

Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study

M. L. Morieri, I. Raz, A. Consoli, M. Rigato, A. Lapolla, F. Broglio, E. Bonora, A. Avogaro, G. P. Fadini

Summary: This study compared the effectiveness of dapagliflozin to DPP-4 inhibitors in achieving individualized HbA1c targets and extra-glycaemic endpoints in elderly patients with type 2 diabetes. The results showed that patients initiating dapagliflozin had a lower likelihood of reaching individualized HbA1c targets compared to those initiating DPP-4 inhibitors. However, they experienced greater improvements in body weight and blood pressure.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Article Endocrinology & Metabolism

Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes

Ernesto Maddaloni, Lucia Coraggio, Rocco G. Amendolara, Marco G. Baroni, Maria Cavallo, Massimiliano Copetti, Efisio Cossu, Paola D'Angelo, Luca D'Onofrio, Salvatore De Cosmo, Frida Leonetti, Susanna Morano, Lelio Morviducci, Nicola Napoli, Sabrina Prudente, Giuseppe Pugliese, Kyoungmin R. Park, Rury Holman, Vincenzo Trischitta, Raffaella Buzzetti, UMMER Study Diabet Grp

Summary: This study evaluated the possible associations of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease (CVD) and diabetic retinopathy (DR) in type 2 diabetes patients. The findings showed that osteocalcin was associated with CVD, while osteoprotegerin and osteopontin were associated with DR.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Article Biochemistry & Molecular Biology

Neurotensin Gene rs2234762 C>G Variant Associates with Reduced Circulating Pro-NT Levels and Predicts Lower Insulin Resistance in Overweight/Obese Children

Federica Sentinelli, Ilaria Barchetta, Flavia Agata Cimini, Sara Dule, Diego Bailetti, Efisio Cossu, Arcangelo Barbonetti, Maria Totaro, Olle Melander, Maria Gisella Cavallo, Marco Giorgio Baroni

Summary: Neurotensin (NT) is a small protein that regulates energy balance and functions as both a neurotransmitter in the brain and a gastrointestinal peptide. This study aimed to investigate the genetic regulation of plasma pro-NT levels. Seven sequence variations in the NT gene (NTS) were identified, including a polymorphism (rs2234762) that was more frequent in individuals with lower pro-NT levels. Carriers of the rs2234762 variant had lower pro-NT levels and reduced insulin resistance, independent of metabolic confounders. This suggests that the NTS rs2234762 gene variant may contribute to a more favorable metabolic profile in overweight and obese children.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Dynamic Changes of BVRA Protein Levels Occur in Response to Insulin: A Pilot Study in Humans

Flavia Agata Cimini, Antonella Tramutola, Ilaria Barchetta, Valentina Ceccarelli, Elena Gangitano, Simona Lanzillotta, Chiara Lanzillotta, Maria Gisella Cavallo, Eugenio Barone

Summary: BVRA protein levels can change dynamically in response to insulin and are greater in individuals with lower insulin sensitivity, indicating a correlation with insulin resistance and secretion.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Endocrinology & Metabolism

Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus

Alessandro Csermely, Alessandro Mantovani, Mario Luca Morieri, Luisa Palmisano, Maria Masulli, Efisio Cossu, Marco Giorgio Baroni, Katia Bonomo, Flavia Agata Cimini, Gisella Cavallo, Raffaella Buzzetti, Carmen Mignogna, Frida Leonetti, Simonetta Bacci, Roberto Trevisan, Riccardo Maria Pollis, Raffaella Aldigeri, Alessandra Dei Cas, Saula Vigili de Kreutzenberg, Giovanni Targher

Summary: A study of 1,417 adult T1DM patients found that the prevalence of MAFLD with significant fibrosis was lower in those using CSII therapy compared to MDI therapy, primarily due to age differences.

DIABETES & METABOLISM (2023)

Letter Endocrinology & Metabolism

Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study

Ernesto Maddaloni, Angela Carlone, Dario Pitocco, Giulia Leanza, Concetta Suraci, Maria G. Altomare, Maria Cavallo, Ilaria Barchetta, Susanna Morano, Chiara Moretti, Lucia Coraggio, Natalia Visalli, Flavia Tramontana, Riccardo Schiaffini, Antonino Crino, Raffaella Buzzetti, Paolo Pozzilli, MDIAB study grp

DIABETES OBESITY & METABOLISM (2023)

Article Endocrinology & Metabolism

Validation in type 2 diabetes of a metabolomic signature of all-cause mortality

Massimiliano Copetti, Marco Giorgio Baroni, Raffaella Buzzetti, Maria Gisella Cavallo, Efiso Cossu, Paola D'Angelo, Salvatore De Cosmo, Frida Leonetti, Susanna Morano, Lelio Morviducci, Nicola Napoli, Sabrina Prudente, Giuseppe Pugliese, Antonio Fernando Savino, Vincenzo Trischitta

Summary: This study aimed to validate the association of a 14-metabolite score with all-cause mortality in type 2 diabetes and explore whether it could improve existing mortality prediction models. The results showed a significant association between the 14-metabolite score and mortality in type 2 diabetes, although the effect size was lower compared to the general population. However, a simplified version of the score without two specific metabolites improved patient analysis and classification of mortality risk.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Review Biochemistry & Molecular Biology

Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?

Valentina Maria Cambuli, Marco Giorgio Baroni

Summary: This article provides a synthetic overview of research in the treatment of type 1 diabetes, focusing on the development of intelligent insulins and the use of artificial intelligence in automated insulin therapy. It outlines the latest developments in the search for intelligent insulins and the promising advances in the use of artificial intelligence for glucose control. The future of insulin treatment in type 1 diabetes appears promising with the potential for a closed-loop artificial pancreas.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Reduced High-Density Lipoprotein Cholesterol Is an Independent Determinant of Altered Bone Quality in Women with Type 2 Diabetes

Sara Dule, Ilaria Barchetta, Flavia Agata Cimini, Giulia Passarella, Arianna Dellanno, Tiziana Filardi, Vittorio Venditti, Enrico Bleve, Diego Bailetti, Elisabetta Romagnoli, Susanna Morano, Marco Giorgio Baroni, Maria Gisella Cavallo

Summary: Type 2 diabetes mellitus is associated with increased fracture risk. This study aimed to explore differences in bone alterations between women with type 2 diabetes and controls, and to identify clinical predictors of bone impairment in type 2 diabetes. The results showed that type 2 diabetes patients had a lower normal bone category and their bone status was correlated with high-density lipoprotein cholesterol and vitamin D levels.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Pharmacology & Pharmacy

Analysis of prognostic factors in COVID-19 hospitalized patients: an Italian single-center case-control study

A. Concistre, L. Petramala, C. L. Pugliano, M. Celi, F. Vinci, E. Assanto, I. Barchetta, E. P. Perrone, S. Rella, F. Iannazzo, A. Angheloni, L. Coraggio, F. Di Rienzo, D. Maggi, F. Circosta, G. Galardo, M. Muscaritoli, C. Letizia

Summary: COVID-19 clinical presentation varies greatly, and identifying high-risk patients is crucial for early treatment and intensive follow-up. This study investigated negative prognostic factors in hospitalized COVID-19 patients.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES (2023)

暂无数据